You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DNA Virus Infections

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Respiratory Tract Diseases, Tumors, Tumors by Histologic Type Trial run by the National Cancer Institute (NCI) (Bevacizumab)

Not yet recruiting
  • Respiratory Tract Diseases
  • +14 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 10, 2023

Verification of Harmonization of Plasma Epstein-Barr Virus DNA

Recruiting
  • Nasopharyngeal Carcinoma
  • Plasma EBV DNA qPCR test
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 3, 2022

Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for

Recruiting
  • Nasopharyngeal Carcinoma
  • EBV antibodies test
  • EBV DNA test
  • Guangzhou, Guangdong, China
    Department of Nasopharyngeal Carcinoma, Sun Yat-sen University C
Jul 6, 2022

Epstein-Barr Virus Infection moniToring in renAl Transplant

Recruiting
  • EBV Infection
  • +3 more
  • EBV DNA in whole blood and plasma
  • Aarhus, Central Region Denmark, Denmark
  • +2 more
Dec 12, 2022

Chronic Hepatitis, Hepatitis C Infection Trial in Puerto Rico, United States (Electroporation-Mediated Plasmid DNA Vaccine

Active, not recruiting
  • Chronic Hepatitis
  • Hepatitis C Infection
  • Electroporation-Mediated Plasmid DNA Vaccine Therapy
  • +4 more
  • Jacksonville, Florida
  • +4 more
Sep 20, 2022

Oropharynx Cancer, Oropharynx Squamous Cell Carcinoma, Carcinoma, Squamous Cell Trial in Aarhus, Copenhagen, Odense (radiation,

Recruiting
  • Oropharynx Cancer
  • +18 more
  • Intensity-Modulated Radiation Therapy (IMRT)
  • +3 more
  • Aarhus, Denmark
  • +2 more
Sep 28, 2021

Common Wart, Warts Hand, Warts Trial in United States (VP-102 Cantharidin topical film forming solution, VP-102 Cantharidin,

Completed
Has Results
  • Common Wart
  • +11 more
  • VP-102 Cantharidin topical film forming solution
  • VP-102 Cantharidin, topical film forming solution
  • Little Rock, Arkansas
  • +4 more
Aug 5, 2021

Nasopharyngeal Carcinoma Trial in Guangzhou (sintilimab, Capecitabine)

Active, not recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 17, 2022

Saliva EBV-DNA Detection in EBV Infection Related Diseases

Recruiting
  • EBV Infection
  • Saliva Testing
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Mar 30, 2022

DNA and RNA Viruses of Blood Virome of Allogeneic Hematopoietic

Completed
  • Hematopietic Stem Cell Transplantation
  • +3 more
  • Real time PCR and RT-PCR for DNA and RNA viral species
  • Geneva, Switzerland
    University Hospitals of Geneva
Jan 19, 2021

Occult Hepatitis B Virus Infection(OBI) in Chronic Hepatitis

Recruiting
  • Chronic Hepatitis b
  • test of HBV DNA
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an JiaotongUniversity
Mar 28, 2022

Immunotherapy With Pembrolizumab for Nasopharyngeal Carcinoma Patients Trial in Taiwan (Pembrolizumab)

Terminated
  • Immunotherapy With Pembrolizumab for Nasopharyngeal Carcinoma Patients
  • Changhua, Taiwan
  • +7 more
Apr 5, 2022

Hantavirus Pulmonary Infection, Immunisation Trial in Cincinnati (Andes virus DNA vaccine, Placebo)

Completed
Has Results
  • Hantavirus Pulmonary Infection
  • Immunisation
  • Andes virus DNA vaccine
  • Placebo
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center - Infectious Disea
Sep 16, 2021

COVID-19, Infection Viral, Infections Trial in Bergen, Oslo (VB10.2129, VB10.2210)

Active, not recruiting
  • COVID-19
  • +2 more
  • VB10.2129
  • VB10.2210
  • Bergen, Norway
  • +1 more
Jan 6, 2023

Nasopharyngeal Cancer, Epstein-Barr Virus Infections Trial in Hong Kong (Recombinant Epstein-Barr Virus (EBV) Vaccine)

Completed
  • Nasopharyngeal Cancer
  • Epstein-Barr Virus Infections
  • Recombinant Epstein-Barr Virus (EBV) Vaccine
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
Jul 26, 2021

HIV Trial in Switzerland, United States (DNA Nat-B env, DNA CON-S env, DNA Mosaic env)

Completed
  • HIV Infections
  • DNA Nat-B env
  • +7 more
  • Birmingham, Alabama
  • +6 more
Oct 13, 2021

Human Immunodeficiency Virus (HIV) Trial in Rochester (Ixazomib 1 MG, Ixazomib 2 MG, Ixazomib 3 MG)

Completed
Has Results
  • Human Immunodeficiency Virus (HIV)
  • Ixazomib 1 MG
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Dec 8, 2021

Zika Virus, Zika Virus Infection, Virus Diseases Trial in Worldwide (VRC-ZKADNA090-00-VP, VRC-PBSPLA043-00-VP)

Completed
Has Results
  • Zika Virus
  • +6 more
  • VRC-ZKADNA090-00-VP
  • VRC-PBSPLA043-00-VP
  • Miami, Florida
  • +16 more
Apr 30, 2021

Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])

Recruiting
  • Influenza
  • +3 more
  • Influenza vaccine [inactivated]
  • Ekaterinburg, Russian Federation
  • +6 more
Feb 13, 2023

Prevalent Kidney Transplant Recipients Using Torque Teno Virus:

Not yet recruiting
  • Kidney Transplant Infection
  • +2 more
  • Torque teno virus DNA measurement
  • (no location specified)
Apr 19, 2023

PD-1, EBV Infection, Transplant Trial in Beijing (toripalimab injection)

Not yet recruiting
  • PD-1
  • +2 more
  • toripalimab injection
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Jun 27, 2021

Chronic Latent EBV Infection

Recruiting
  • EBV Infection
  • peripheral EBV-DNA load
  • Wuhan, Hubei, China
    Tongji hospital, Tongji medical collage of HUST
Feb 9, 2021

Herpes Virus Infections in Kidney Transplant Patients

Recruiting
  • Kidney Transplant; Complications
  • +2 more
    • Aarhus, Denmark
    • +4 more
    Jan 30, 2023

    Cell-free DNA From Junction of Hepatitis B Virus Integration in

    Active, not recruiting
    • Hepatocellular Carcinoma
      • Taipei, Taiwan
        National Taiwan University Hospital
      Apr 10, 2023

      Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)

      Recruiting
      • Adenovirus Infection
      • +6 more
      • Virus-specific Cytotoxic T-lymphocytes
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 6, 2023